Stock Track | PHARMARON Soars 5.09% Intraday on Capital Increase and Dividend Proposal

Stock Track

03/31

PHARMARON's stock surged 5.09% during Tuesday's intraday trading session, following the announcement of several positive corporate actions.

The company's board has proposed to increase its registered capital from RMB 1.778 billion to RMB 1.837 billion, reflecting recent share placements and vesting of restricted shares. This capital increase typically signals growth plans and expansion initiatives that investors view favorably.

Additionally, PHARMARON announced a proposed final cash dividend of RMB2 for every 10 shares for the financial year ended December 2025, returning value to shareholders. The company also completed a management transition with the appointment of an experienced new company secretary, further strengthening its corporate governance structure.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1130321136"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1130321136\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1130321136?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-31 09:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1130321136","market":"nz","top_or_hot":-1,"title":"Stock Track | PHARMARON Soars 5.09% Intraday on Capital Increase and Dividend Proposal","media":"Stock Track","content":"<p>PHARMARON's stock surged 5.09% during Tuesday's intraday trading session, following the announcement of several positive corporate actions.</p><p>The company's board has proposed to increase its registered capital from RMB 1.778 billion to RMB 1.837 billion, reflecting recent share placements and vesting of restricted shares. This capital increase typically signals growth plans and expansion initiatives that investors view favorably.</p><p>Additionally, PHARMARON announced a proposed final cash dividend of RMB2 for every 10 shares for the financial year ended December 2025, returning value to shareholders. The company also completed a management transition with the appointment of an experienced new company secretary, further strengthening its corporate governance structure.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | PHARMARON Soars 5.09% Intraday on Capital Increase and Dividend Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | PHARMARON Soars 5.09% Intraday on Capital Increase and Dividend Proposal\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2026-03-31 09:47</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>PHARMARON's stock surged 5.09% during Tuesday's intraday trading session, following the announcement of several positive corporate actions.</p><p>The company's board has proposed to increase its registered capital from RMB 1.778 billion to RMB 1.837 billion, reflecting recent share placements and vesting of restricted shares. This capital increase typically signals growth plans and expansion initiatives that investors view favorably.</p><p>Additionally, PHARMARON announced a proposed final cash dividend of RMB2 for every 10 shares for the financial year ended December 2025, returning value to shareholders. The company also completed a management transition with the appointment of an experienced new company secretary, further strengthening its corporate governance structure.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03759","symbol_name":"康龍化成","start_time":0,"source_url":"","article_id":"1130321136","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1130321136","pubTimestamp":1774921649,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"PHARMARON's stock surged 5.09% during Tuesday's intraday trading session, following the announcement of several positive corporate actions.The company's board has proposed to increase its registered...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03759":"康龙化成"},"translate_title":"股票赛道|康龙化成盘中大涨5.09%因增资及派息提案","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03759":1},"content_text":"PHARMARON's stock surged 5.09% during Tuesday's intraday trading session, following the announcement of several positive corporate actions.The company's board has proposed to increase its registered capital from RMB 1.778 billion to RMB 1.837 billion, reflecting recent share placements and vesting of restricted shares. This capital increase typically signals growth plans and expansion initiatives that investors view favorably.Additionally, PHARMARON announced a proposed final cash dividend of RMB2 for every 10 shares for the financial year ended December 2025, returning value to shareholders. The company also completed a management transition with the appointment of an experienced new company secretary, further strengthening its corporate governance structure.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}